StockData
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. (PHIO) stock

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$0.77−0.04 (-5.03%)

Close on Nov 13, 2026Market cap $8.96MP/E –Yield –

Phio Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Phio Pharmaceuticals's price to book ratio was 0.7× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.2× to 1.2×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×+0.1
2025Dec 31, 20250.6×+0.3
2024Dec 31, 20240.3×+0.1
2023Dec 29, 20230.2×−0.1
2022Dec 30, 20220.4×−0.2
2021Dec 31, 20210.5×−0.5
2020Dec 31, 20201.0×+0.4
2019Dec 31, 20190.6×−0.3
2018Dec 31, 20180.8×−3.0
2017Dec 29, 20173.8×+2.3
2016Dec 30, 20161.6×−0.7
2015Dec 31, 20152.2×−5.0
2014Dec 31, 20147.2×+2.4
2013Dec 31, 20134.9×–

More Phio Pharmaceuticals figures

See a number that looks wrong?